Literature DB >> 21289304

OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Takanori So1, Heonsik Choi, Michael Croft.   

Abstract

T lymphocyte activation requires signal 1 from the TCR and signal 2 from costimulatory receptors. For long-lasting immunity, growth and survival signals imparted through the Akt/protein kinase B (PKB) pathway in activated or effector T cells are important, and these can be strongly influenced by signaling from OX40 (CD134), a member of the TNFR superfamily. In the absence of OX40, T cells do not expand efficiently to Ag, and memory formation is impaired. How most costimulatory receptors integrate their signals with those from Ag through the TCR is not clear, including whether OX40 directly recruits PKB or molecules that regulate PKB. We show that OX40 after ligation by OX40L assembled a signaling complex that contained the adapter TNFR-associated factor 2 as well as PKB and its upstream activator phosphoinositide 3-kinase (PI3K). Recruitment of PKB and PI3K were dependent on TNFR-associated factor 2 and on translocation of OX40 into detergent-insoluble membrane lipid microdomains but independent of TCR engagement. However, OX40 only resulted in strong phosphorylation and functional activation of the PI3K-PKB pathway when Ag was recognized. Therefore, OX40 primarily functions to augment PKB signaling in T cells by enhancing the amount of PI3K and PKB available to the TCR. This highlights a quantitative role of this TNFR family second signal to supplement signal 1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289304      PMCID: PMC3079230          DOI: 10.4049/jimmunol.1003156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.

Authors:  A J Coyle; S Lehar; C Lloyd; J Tian; T Delaney; S Manning; T Nguyen; T Burwell; H Schneider; J A Gonzalo; M Gosselin; L R Owen; C E Rudd; J C Gutierrez-Ramos
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

2.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

3.  Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.

Authors:  Hideki Sanjo; Dirk M Zajonc; Rebecca Braden; Paula S Norris; Carl F Ware
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

4.  Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo.

Authors:  Y Harada; M Tokushima; Y Matsumoto; S Ogawa; M Otsuka; K Hayashi; B D Weiss; C H June; R Abe
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

Review 5.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.

Authors:  T O Chan; S E Rittenhouse; P N Tsichlis
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

6.  The E3 ligase TRAF6 regulates Akt ubiquitination and activation.

Authors:  Wei-Lei Yang; Jing Wang; Chia-Hsin Chan; Szu-Wei Lee; Alejandro D Campos; Betty Lamothe; Lana Hur; Brian C Grabiner; Xin Lin; Bryant G Darnay; Hui-Kuan Lin
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

7.  c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.

Authors:  Jae J Song; Joo-Hang Kim; Bo K Sun; Marco A Alcala; David L Bartlett; Yong J Lee
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

Review 8.  The significance of OX40 and OX40L to T-cell biology and immune disease.

Authors:  Michael Croft; Takanori So; Wei Duan; Pejman Soroosh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

9.  Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.

Authors:  R G Jones; M Parsons; M Bonnard; V S Chan; W C Yeh; J R Woodgett; P S Ohashi
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

10.  TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation.

Authors:  Björn F Lillemeier; Manuel A Mörtelmaier; Martin B Forstner; Johannes B Huppa; Jay T Groves; Mark M Davis
Journal:  Nat Immunol       Date:  2009-12-13       Impact factor: 25.606

View more
  39 in total

1.  New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.

Authors:  Xiang Xiao; Weihua Gong; Gulcin Demirci; Wentao Liu; Silvia Spoerl; Xiufeng Chu; D Keith Bishop; Laurence A Turka; Xian C Li
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

Review 2.  Strategies for combining immunotherapy with radiation for anticancer therapy.

Authors:  Steven N Seyedin; Jonathan E Schoenhals; Dean A Lee; Maria A Cortez; Xiaohong Wang; Sharareh Niknam; Chad Tang; David S Hong; Aung Naing; Padmanee Sharma; James P Allison; Joe Y Chang; Daniel R Gomez; John V Heymach; Ritsuko U Komaki; Laurence J Cooper; James W Welsh
Journal:  Immunotherapy       Date:  2015-08-27       Impact factor: 4.196

Review 3.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 4.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

5.  Immunochip-based analysis: high-density genotyping of immune-related loci sheds further light on the autoimmune genetic architecture of alopecia areata.

Authors:  Silke Redler; Marina Angisch; Stefanie Heilmann; Sabrina Wolf; Sandra Barth; Buket F Basmanav; Kathrin A Giehl; Sandra Hanneken; Sibylle Eigelshoven; Elisabeth Mangold; Roland Kruse; Bettina Blaumeiser; Markus Böhm; Michael Knapp; Natalie Garcia Bartels; Gerhard Lutz; Hans Wolff; Ulrike Blume-Peytavi; Markus M Nöthen; Tim Becker; Regina C Betz
Journal:  J Invest Dermatol       Date:  2014-10-22       Impact factor: 8.551

6.  LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required.

Authors:  L Wang; J Ren; G Li; J P Moorman; Z Q Yao; S Ning
Journal:  Oncogene       Date:  2016-11-07       Impact factor: 9.867

Review 7.  Signals that drive T follicular helper cell formation.

Authors:  Louise M C Webb; Michelle A Linterman
Journal:  Immunology       Date:  2017-07-17       Impact factor: 7.397

8.  OX40 Cooperates with ICOS To Amplify Follicular Th Cell Development and Germinal Center Reactions during Infection.

Authors:  Vikas Tahiliani; Tarun E Hutchinson; Georges Abboud; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

Review 9.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  mTOR, metabolism, and the regulation of T-cell differentiation and function.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.